Skip to main content

PharmacoEconomics

Ausgabe 11/2016

Inhalt (11 Artikel)

Editorial

From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare

Matthijs Versteegh, Saskia Knies, Werner Brouwer

Open Access Practical Application

Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation

Padraig Dixon, George Davey Smith, Stephanie von Hinke, Neil M. Davies, William Hollingworth

Systematic Review

Economic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies

Feng Xie, Bruno Kovic, Xuejing Jin, Xiaoning He, Mengxiao Wang, Camila Silvestre

Review Article

The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critique of the Evidence

Eleftherios Sideris, Mark Corbett, Stephen Palmer, Nerys Woolacott, Laura Bojke

Review Article

A Methodological Review of US Budget-Impact Models for New Drugs

Josephine Mauskopf, Stephanie Earnshaw

Original Research Article

Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UK

Jamie Elvidge, Ash Bullement, Anthony J. Hatswell

Original Research Article

Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations

Cynthia P. Iglesias, Alexander Thompson, Wolf H. Rogowski, Katherine Payne

Original Research Article

Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience

François Bocquet, Anaïs Loubière, Isabelle Fusier, Anne-Laure Cordonnier, Pascal Paubel

Letter to the Editor

Discretely Integrated Condition Event Simulation for Pharmacoeconomics

Mondher Toumi, Ekkehard Beck, Steve Sherman, Leyla Mohseninejad, Samuel Aballéa